RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bio-Techne Stock

Bio-Techne Dividend 2024

Bio-Techne Dividend

0.24 USD

Bio-Techne Dividend yield

0.32 %

Ticker

TECH

ISIN

US09073M1045

WKN

A12ENG

How much dividend does Bio-Techne 2024 pay?

According to the latest status from September 2024, Bio-Techne paid a total of 0.24 USD per share in dividends within the last 12 months. With the current Bio-Techne price of 75.28 USD, this corresponds to a dividend yield of 0.32 %. A dividend is paid 4 times per year.

0.32 % Dividend Yield=
0.24 USD Dividend
75.28 USD Stock Price

Historical Bio-Techne Dividends

A dividend is paid 4 times per year. Last year, the payout months were March, June, September, December and December.

PaydateDividend
9/19/20240.08
6/10/20240.08
3/9/20240.08
12/9/20230.08
12/8/20230.08
9/17/20230.08
6/12/20230.08
3/10/20230.08
12/10/20220.32
9/12/20220.32
6/13/20220.32
3/25/20220
3/10/20220.32
2/28/20220
1/30/20220
12/11/20210.32
12/10/20210.32
9/13/20210.32
6/14/20210.32
3/11/20210.32
1
2
3
4

Bio-Techne dividend history and estimates

In 2023, Bio-Techne paid a dividend amounting to 0.56 USD. Dividend means that Bio-Techne distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Bio-Techne provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Bio-Techne’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Bio-Techne's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Bio-Techne Dividend History

DateBio-Techne Dividend
2028e0.24 undefined
2027e0.24 undefined
2026e0.24 undefined
2025e0.24 undefined
20240.24 undefined
20230.56 undefined
20221.04 undefined
20211.6 undefined
20201.28 undefined
20191.28 undefined
20181.28 undefined
20171.28 undefined
20161.6 undefined
20151.28 undefined
20141.25 undefined
20131.21 undefined
20121.14 undefined
20111.09 undefined
20101.05 undefined
20091.01 undefined
20080.25 undefined

Is the Bio-Techne Dividend Safe?

Bio-Techne has been increasing the dividend for 1 years.

Over the past 10 years, Bio-Techne has increased it by an annual -15.213 %.

Over a five-year period, the distribution increased by -28.452%.

Analysts expect a Dividend Increase of 0.156% for the current fiscal year.

Bio-Techne dividend payout ratio

In 2023, Bio-Techne had a payout ratio of 111.74%. The payout ratio indicates the percentage of the company's profits that Bio-Techne distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Bio-Techne represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Bio-Techne could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Bio-Techne's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Bio-Techne Payout Ratio History

DateBio-Techne Payout ratio
2028e105.65 %
2027e109.13 %
2026e109.78 %
2025e98.05 %
2024119.56 %
2023111.74 %
202262.84 %
2021184.09 %
202088.28 %
2019206.45 %
2018156.1 %
2017250.98 %
2016228.57 %
2015177.78 %
2014166.67 %
2013159.21 %
2012150 %
2011143.42 %
2010143.84 %
2009146.38 %
200837.88 %
2007111.74 %
2006111.74 %
2005111.74 %

Dividend Details

Understanding Bio-Techne's Dividend Distributions

Bio-Techne’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Bio-Techne's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Bio-Techne's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Bio-Techne’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Bio-Techne Aktienanalyse

What does Bio-Techne do?

Bio-Techne Corp is a global company specializing in the research and development of innovative products and solutions in the field of biosciences. The company was founded in 1976 in Minneapolis and was formerly known as Techne Corporation. Since then, it has grown into an internationally renowned company through its numerous acquisitions and mergers. The company is headquartered in Minneapolis, Minnesota, USA. The business philosophy of Bio-Techne Corp is to help bioscientific researchers and clinicians around the world perform their work more effectively, efficiently, and quickly. The company works closely with its customers to provide them with suitable products and services, thereby developing innovative solutions to the challenges in bioscience. Bio-Techne Corp has various business segments, including protein platforms, diagnostics, genetic analysis, clinical controls, cell culture products, and research reagents. Each business segment offers a variety of products and services to support researchers and clinicians in their work. A key business segment of Bio-Techne Corp is the protein platform, which offers a comprehensive range of proteins, antibodies, and corresponding detection reagents. The company is known for its high-quality proteins and antibodies, which contribute to improving the research of diseases such as cancer, diabetes, and neurological and immunological disorders. Another important business segment of Bio-Techne Corp is diagnostics. Here, the company offers a wide range of clinical diagnostic products, such as tests for analyzing urea, creatinine, and bone density. The company's products help clinicians make precise diagnoses and treat patients more effectively. The genetic analysis segment offers DNA sequencing, gene expression, and genome-wide analysis products and services. These tools enable researchers to better understand the functioning of the human body by exploring the underlying genetic changes. The clinical controls segment offers product and service offerings that improve the reliability and accuracy of diagnostic systems. The company works closely with medical facilities to provide diagnostic solutions that deliver fast and accurate results. The cell culture products segment offers a complete range of solutions for cell cultivation and growth. The offering ranges from basic nutrient media and additives to culture vessels and accessories. The company's products enable researchers to culture cells in a controlled environment and under precise conditions. The last segment of Bio-Techne Corp includes research reagents. Here, the company offers a wide range of reagents used for protein, antibody, and cell function analysis and research. The products meet the needs of researchers in modern bioscience. In summary, Bio-Techne Corp is a company specialized in developing innovative solutions in bioscience, advancing science and medicine. With its products and services offered in various sectors, the company successfully helps researchers and clinicians perform their work faster, more effectively, and cost-efficiently. Bio-Techne is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Bio-Techne stock

How much dividend does Bio-Techne pay?

Over the past 12 months, Bio-Techne paid a dividend of 0.24 USD . This corresponds to a dividend yield of about 0.32 %. For the coming 12 months, Bio-Techne is expected to pay a dividend of 0.24 USD.

What is the dividend yield of Bio-Techne?

The current dividend yield of Bio-Techne is 0.32 %.

When does Bio-Techne pay dividends?

Bio-Techne pays a quarterly dividend. This is distributed in the months of December, March, June, September.

How secure is the dividend of Bio-Techne?

Bio-Techne paid dividends every year for the past 21 years.

What is the dividend of Bio-Techne?

For the upcoming 12 months, dividends amounting to 0.24 USD are expected. This corresponds to a dividend yield of 0.32 %.

In which sector is Bio-Techne located?

Bio-Techne is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bio-Techne kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bio-Techne from 8/30/2024 amounting to 0.08 USD, you needed to have the stock in your portfolio before the ex-date on 8/19/2024.

When did Bio-Techne pay the last dividend?

The last dividend was paid out on 8/30/2024.

What was the dividend of Bio-Techne in the year 2023?

In the year 2023, Bio-Techne distributed 0.56 USD as dividends.

In which currency does Bio-Techne pay out the dividend?

The dividends of Bio-Techne are distributed in USD.

Andere Kennzahlen von Bio-Techne

Our stock analysis for Bio-Techne Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bio-Techne Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.